Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study

被引：0
|
作者：
Hutchinson, M. [1 ]
Fox, R. J. [2 ]
Phillips, J. T. [3 ]
Miller, D. H. [4 ]
Havrdova, E. [5 ]
Kita, M. [6 ]
Yang, M. [7 ]
Zhang, R. [7 ]
Novas, M. [7 ]
Sweetser, M. T. [7 ]
Viglietta, V. [7 ]
Dawson, K. T. [7 ]
机构：
[1] St Vincents Univ Hosp, Dublin 4, Ireland
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] UCL, Inst Neurol, NMR Res Unit, London, England
[5] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic
[6] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[7] Biogen Idec Inc, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：683 / 683
页数：1
相关论文
共 50 条
  • [31] Safety and tolerability of BG-12 in the phase 3 DEFINE trial in patients with relapsing-remitting multiple sclerosis
    Selmaj, K.
    Gold, R.
    Kappos, L.
    Bar-Or, A.
    Arnold, D.
    Giovannoni, G.
    Sweetser, M.
    Novas, M.
    Raghupathi, K.
    Dawson, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S451 - S451
  • [32] Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Kita, Mariko
    Fox, Robert J.
    Phillips, J. Theodore
    Hutchinson, Michael
    Havrdova, Eva
    Sarda, Sujata P.
    Agarwal, Sonalee
    Kong, Jessica
    Zhang, Annie
    Viglietta, Vissia
    Sheikh, Sarah I.
    Seidman, Emily
    Dawson, Katherine T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 253 - 257
  • [33] An integrated analysis of the clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S13 - S13
  • [34] CLINICAL AND NEURORADIOLOGICAL EFFECT OF BG-12 (DIMETHYL FUMARATE) IN SUBGROUPS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): AN INTEGRATED ANALYSIS OF THE PHASE 3 DEFINE AND CONFIRM STUDIES
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S., I
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A102 - A102
  • [35] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study
    Amit Bar-Or
    Ralf Gold
    Ludwig Kappos
    Douglas L. Arnold
    Gavin Giovannoni
    Krzysztof Selmaj
    John O’Gorman
    Monica Stephan
    Katherine T. Dawson
    [J]. Journal of Neurology, 2013, 260 : 2297 - 2305
  • [36] Safety and Tolerability of Oral BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): Interim Results from ENDORSE Extension Study
    Phillips, J. Theodore
    Fox, Robert
    Selmaj, Krzysztof
    Raghupathi, Kartik
    Yuan, Huixing
    Novas, Mark
    Sweetser, Marianne
    Viglietta, Vissia
    Dawson, Katherine
    Gold, Ralf
    [J]. NEUROLOGY, 2013, 80
  • [37] Safety and Tolerability of BG-12 (Dimethyl Fumarate) in Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of Phase 2 and 3 Placebo-Controlled Studies
    Phillips, J. Theodore
    Fox, Robert
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Raghupathi, Kartik
    Yuan, Huixing
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Novas, Mark
    Sweetser, Marianne
    Selmaj, Krzysztof
    [J]. NEUROLOGY, 2013, 80
  • [38] Effects of BG-12 on quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Kita, M.
    Fox, R. J.
    Phillips, J. T.
    Hutchinson, M.
    Havrdova, E.
    Sarda, S. P.
    Kong, J.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 254 - 254
  • [39] An integrated analysis of safety and tolerability of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from phase 2 and 3 placebo-controlled studies
    Phillips, J. T.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Raghupathi, K.
    Yuan, H.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    Novas, M.
    Sweetser, M. T.
    Selmaj, K.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S75 - S75
  • [40] Clinical outcomes with BG-12 treatment in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a multicentre, randomised, placebo-controlled, phase 3 study
    Havrdova, E.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Hutchinson, M.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S36 - S36
12345